Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates 
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits 
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production 
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny 
VANCOUVER, Washington, April 06, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that management will hold an investment community conference call on Tuesday, April 18, 2017, at 1:00 p.m. PT / 4:00 p.m. ET to provide an update on clinical trial and regulatory developments.
Conference Call and Webcast Instructions
Interested participants and investors may access this conference call by dialing 877-407-2986 (U.S./Canada) or 201-378-4916 (international).
A live audio webcast may also be accessed via CytoDyn’s corporate website at www.cytodyn.com under the Investors section/IR Calendar and will be archived for 60 days. Web participants are encouraged to go to the website 15 minutes prior to the start of the call to register, download and install any necessary software. The webcast can also be accessed via the following link:
http://cytodyn.equisolvewebcast.com/4-18-17.
A replay of the conference call will be available until June 18, 2017. To access the replay, interested parties may dial 877-660-6853 (U.S./Canada) or 201-612-7415 (international); Conference ID: 13652328.
CONTACTS: Investors: LHA Jody Cain Office: 310-691-7100 E-mail: [email protected] Media: Nader Pourhassan, Ph.D. President & CEO Office: 360-980-8524 Email: [email protected]
